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A B S T R A C T  
Central giant cell granuloma (CGCG) is a benign non odontogenic lesion of jaw that may show aggressive behavior. It is 
classified as aggressive and non-aggressive lesion on the basis of biological behavior and radiographic features. Central 
giant cell lesion is more frequent in children and young adult before the age of 30 years with female predilection, with 
characteristic radiological and histopathological features. Here we present a case of a 35 years old female with clinical 
and radiological diagnosis of central giant cell lesion in posterior mandible confirmed by histopathology. A surgical 
approach with regular follow up is the treatment of choice in most of the cases. 
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I n t r o d u ct i on  
Central giant cell granuloma (CGCG) is a giant cell 
lesion, that represents a benign proliferation of 
fibroblasts and multinucleated giant cells.1 Kaban 
and colleagues formalized a classification system 
that provides a guide for treatment.2 The biological 
behavior can be aggressive or non-aggressive, in 
which aggressive form exhibits numerous symptoms 
whereas non aggressive is asymptomatic.1 The 
aggressive form has any three of the following 
criteria; greater than 5cm, painful, rapid growth, 
root resorption, tooth displacement, cortical bone 
thinning or perforation, extension into soft tissue, 
ulceration of overlying mucosa and recurrence. The 
non-aggressive lesion is relatively small, painless, 
exhibits few or no symptoms, grows slowly, and 
does not cause root perforation or root resorption.1 
Central giant cell granuloma mostly occurs in 
children and young adults with female predilection. 
The mandible is affected more frequently than 
maxilla (3:1), mostly anterior to the first permanent 
molar teeth. Lesion may be seen crossing midline.1 
Central giant cell granuloma resembles other giant 
cell lesions so proper clinical examination, 
histological and radiographic analysis, helps to 
differentiate it from these lesions.3 
C a s e  R e p o r t  
A 35 years old female came to Oral and Maxillofacial 
Surgery Department with complaint of pain and 
swelling on the right side of lower jaw, which 
appeared 6 months back. Patient was referred by a 
general dentist. Pain radiated to the head region and 
was only relieved by analgesics. Swelling 
progressively increased in size due to which patient 
was unable to eat. It was not associated with fever, 
chills, rigors and lymphadenopathy. 
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Past medical, surgical, drug and family history were 
unremarkable. Patient was a housewife with 3 
children and belonged to a middle-class family. She 
was well oriented in time place and person. There 
was no anemia, jaundice, cyanosis, clubbing or 
lymphadenopathy. On clinical examination, there 
was facial asymmetry due to swelling on right lower 
side of the face. Mouth opening was adequate with 
a firm swelling of approximately 5cm, extending 
superiorly to occlusal level of teeth, inferiorly to 
buccal vestibule, anteriorly to first premolar and 
posteriorly to third molar region. The overlying 
mucosa was normal. Teeth associated with swelling 
were mobile.  
Baseline investigations were normal. Ortho-
pantomograph revealed radiolucent swelling 
4cm×2cm in size on right posterior mandible with 
bone resorption and displacement of associated 
teeth (Figure 1). On Incisional biopsy, microscopic 
features such as few multinucleated giants in a 
background of plump proliferating mesenchymal 
cells along with red blood cells extravasation 
confirmed central giant cell granuloma (CGCG). 
Surgery was performed under General anesthesia 
with enucleation (complete removal of lesion) and 
curettage, along with extraction of the associated 
teeth and peripheral ostectomy to prevent 
recurrence. First, incision was marked to ensure that 
it was placed over an area of sound bone that allow 
for adequate tissue closure as placement of incision 
over a bony defect may allow the wound to break 
down in to the lesion cavity. A small round bur was 
used for lateral corticotomy and sharp double end 
curette was used for enucleation. The sharp end of 
curette was used between the lesion and against the 
bone to allow proper enucleation of the lesion and 
minimize the occurrence of a tear. The cavity was 
then examined for any remnant. A peripheral 
ostectomy was completed with large round 
diamond bur with copious irrigation to remove 1-2 
mm of surrounding bone until the cavity was 
completely cleared. Post-removal examination of 
lesion was done (Figure 2). Written consent was 
signed by the patient in which the disease, 
complications of disease and surgery and prognosis 
of surgical treatment was clearly explained. 
Patient was recalled weekly for follow-up. In each 
visit wound was examined carefully, irrigated, 
dressing was placed in the intraoral wound to 
promote healing. Rehabilitation with prosthesis was 
planned after complete wound healing. 
Figure 1: OPG showing radiolucency on right posterior 
mandible with bone resorption and teeth displacement.  
 
 
Figure 2: Gross specimen of CGCG after enucleation and 
peripheral ostectomy 
 
D i s c u s s i o n  
World health organization classified central giant 
cell granuloma in 2005 as the rarely aggressive 
lesion of jaw that may be asymptomatic or present 
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with pain, paresthesia and bone perforation.4 Jaffee 
(1953) considered this lesion as reparative reaction 
of bone.5,6 Cossío et al suggested that trauma is the 
main cause of CGCG.7 Soames and Southam (1997) 
suggested that it could be a reaction to bone 
marrow hemodynamic disturbance .There are many 
orofacial giant cell lesions that have similar 
presentation so surgeon should have proper 
knowledge of histopathological and radiographic 
features to differentiate, diagnose and manage the 
lesion. 
CGCG is frequently reported in females less than 30 
years of age with anterior mandible as the most 
commonly affected site.4 However, our case was a 
35 years old female with the lesion in posterior 
mandible. Medical treatment of this lesion includes 
intralesional corticosteroid injections for 6 weeks, 
subcutaneous calcitonin injections for 1 year, 
interferon alpha-2b subcutaneous injections or 
combination.8,9 Surgical treatment options include 
curettage alone (with more chances of recurrence) 
or curettage with enucleation, resection and 
peripheral ostectomy as the best treatment option.4 
Intraoperative complications of these surgical 
procedures include damage to adjacent teeth and 
nerves, bleeding, and tearing of lesion lining. Post-
operative complications include infection, wound 
dehiscence, graft failure, facial asymmetry, and 
recurrence.10 
C o n c l u s i on  
Central giant cell granuloma belongs to giant cell 
lesion group with unknown etiology. This 
pathological lesion is managed by taking proper 
history, examination, radiographic and, 
histopathological analysis that helps to differentiate 
it from other lesions. There are different treatment 
strategies for central giant cell granuloma with the 
choice depending upon patient's demand, medical 
condition of the patient, severity of the disease and 
surgeon experience. 
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